Share Email Print

Proceedings Paper

Liposomes: bio-inspired nano-containers for physically triggered targeted drug delivery
Author(s): Sofiya Matviykiv; Marzia Buscema; Tamás Mészáros; Gabriela Gerganova; Thomas Pfohl; Andreas Zumbühl; János Szebeni; Bert Müller
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

For natural scientists and engineers, learning from nature has tradition and is often driven by bio-inspired processes and materials. For example, engineers have designed multifunctional materials with hierarchical structures. Lipid bilayers, the principal components of cell membranes, can form vesicles, termed liposomes. Such liposomes are usually recognized as foreign by the immune system of a patient, which makes it challenging to use liposomes as containers for targeted drug delivery. There are, however, promising non-spherical, mechano-sensitive, artificial liposomes about 100 nm in diameter, which were recently identified. These bio-inspired containers offer a wide range of applications. In particular, the targeted release at critically stenosed arteries formed as a result of atherosclerosis significantly reduces the undesired side effects such as a drop of blood pressure. It is well known that FDA-approved liposomal drugs, currently on the market, often induce adverse immune responses. Therefore, to exclude the hypersensitivity of the recently discovered mechano-sensitive liposomes, we have performed in vitro complement activation experiments and related animal studies with pigs. Recently, it has been shown that the drug-free Pad-PC-Pad liposomes surprisingly lack any complement activation. In this study, we demonstrate that nitroglycerin-loaded liposomes with relevant human therapeutic dosage exhibit low complement activation compared to the FDA-approved phospholipid drugs, including Abelcet. Furthermore, the liposomal suspensions applied are stable for a period of more than two months. Consequently, the non-spherical liposomes of nanometer size we have developed are promising containers for physically triggered, targeted drug delivery.

Paper Details

Date Published: 17 April 2017
PDF: 14 pages
Proc. SPIE 10162, Bioinspiration, Biomimetics, and Bioreplication 2017, 101620A (17 April 2017); doi: 10.1117/12.2258378
Show Author Affiliations
Sofiya Matviykiv, Univ. Basel (Switzerland)
Marzia Buscema, Univ. Basel (Switzerland)
Tamás Mészáros, Semmelweis Univ. (Hungary)
SeroScience Ltd. (Hungary)
Gabriela Gerganova, Univ. Basel (Switzerland)
Thomas Pfohl, Univ. Basel (Switzerland)
Andreas Zumbühl, Univ. de Fribourg (Switzerland)
János Szebeni, Semmelweis Univ. (Hungary)
SeroScience Ltd. (Hungary)
Bert Müller, Univ. Basel (Switzerland)

Published in SPIE Proceedings Vol. 10162:
Bioinspiration, Biomimetics, and Bioreplication 2017
Mato Knez; Akhlesh Lakhtakia; Raúl J. Martín-Palma, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?